BPC-157 5mg — 5mgBPC-157 5mg
Quality
Pharmacy grade
Form
Pen with case
Level
beginner
Consultation required · prescriber

BPC-157 5mg

A synthetic 15-amino-acid peptide with predominantly rodent evidence and no established clinical benefit for injury recovery.

£19/ 5mg
Available after consultation
BPC-157 5mg
£19
Start consultation

Answer a short online consultation. A clinician reviews it, and you only pay if treatment is approved. Dispensed by our licensed facility.

BPC-157 is a synthetic pentadecapeptide described as a fragment associated with a protein in gastric juice. It is not an authorised medicine in the UK or USA.
Strength
5mg
Form
Pen with case
Supplied by
Licensed facility

What it is

BPC-157 is a synthetic pentadecapeptide described as a fragment associated with a protein in gastric juice. It is not an authorised medicine in the UK or USA.

Laboratory work examines nitric oxide signalling, blood-vessel formation and cell migration. These proposed mechanisms do not establish meaningful outcomes in people.

Why people ask about it

Interest usually follows tendon, ligament or digestive-health claims online, but such claims substantially exceed the available human evidence.

What the science says

Most published findings come from rodent injury models and cell experiments. Small, uncontrolled human reports cannot establish effectiveness, appropriate selection or long-term safety; robust randomised clinical evidence is lacking.

How Welcuren works

Complete a short online consultation about your health and goals.

A clinician reviews your answers, may ask follow-up questions, and decides whether this treatment is appropriate for you.

You only pay once treatment is approved. Our licensed facility then dispatches it with full instructions, on tracked global delivery.

Safety

Human adverse effects, interactions and contraindications are insufficiently characterised; possible concerns include immune reactions, impurities and uncertain effects on blood-vessel signalling. Pregnancy, breastfeeding and active malignancy require particular caution, and your clinician will advise

Questions

Is BPC-157 a naturally occurring gastric medicine?

The supplied molecule is synthetic; descriptions of gastric origin do not make it an established digestive medicine.

Has BPC-157 been tested for tendon injuries in large trials?

Large, well-controlled human tendon studies have not established a clinical benefit.

Does animal wound data predict my recovery?

Rodent tissue responses cannot reliably predict a person’s recovery or sporting performance.

Is BPC-157 permitted in competitive sport?

BPC-157 is prohibited under the World Anti-Doping Agency category for non-approved substances; athletes should obtain specialist advice.

This information is educational and not a substitute for advice from your clinician. Prescription treatments are only supplied after a clinical consultation.

Often considered together

Many clients start with a blood test so their clinician has a full picture.

ARA-290 (Cibinetide) 10mgARA-290 (Cibinetide) 10mg

ARA-290 (Cibinetide) 10mg

ARA-290 (Cibinetide) 10mg is an investigational erythropoietin-derived peptide, considered only after online consultation and clinician approval.

10mg pen
BPC-157 + TB-500 Blend 10mgBPC-157 + TB-500 Blend 10mg

BPC-157 + TB-500 Blend 10mg

A two-component blend without controlled human evidence that the combination improves recovery or offers added benefit.

10mg total; component quantities require verification
GLOW Blend (BPC-157 + TB-500 + GHK-Cu) 70mgGLOW Blend (BPC-157 + TB-500 + GHK-Cu) 70mg

GLOW Blend (BPC-157 + TB-500 + GHK-Cu) 70mg

GLOW Blend combines BPC-157, TB-500 and GHK-Cu in a branded pre-filled pen, available only following online consultation and clinician approval.

70mg pen